Mei-yan Zhu

发表

Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation

Zhenwei Peng, Yan Wang, Yong Chen, 2022, Journal of oncology.

A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study

Cheng-tao Wang, Yan Wang, Yong Chen, 2019, Journal of Cancer.

Efficacy of Different Treatments for Patients with Advanced Hepatocellular Carcinoma: A System Review and Network Meta-Analysis

Zhenwei Peng, Yan Wang, Yong Chen, 2022, International Journal of Surgery: Oncology.

Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation

Dongmei Jiang, Ran-yi Liu, Zhenwei Peng, 2022, Molecular therapy oncolytics.

pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors.

Zhiqiang Yu, Zhenwei Peng, Wen Ma, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 tri

Zhenwei Peng, L. Cui, Qiang Qin, 2022, EClinicalMedicine.

Near‐Infrared II Light‐Triggered Robust Carbon Radical Generation for Combined Photothermal and Thermodynamic Therapy of Hypoxic Tumors

Xiqiang Liu, Yuanyuan Yang, Zhiqiang Yu, 2021, Advanced Functional Materials.

A novel risk signature based on autophagy-related genes to evaluate tumor immune microenvironment and predict prognosis in hepatocellular carcinoma

Quanxiao Li, Zhenwei Peng, Mei-yan Zhu, 2022, Comput. Biol. Medicine.

Circulating Plasma Epstein-Barr Virus DNA Load During the Follow-up Periods Predicts Recurrence and Metastasis in Nasopharyngeal Carcinoma

Lixia Lu, Yun Yang, Yan Wang, 2020, Cancer journal.

Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization

Minshan Chen, Zhenwei Peng, Yan Wang, 2021, Frontiers in Oncology.

Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy

S. Peng, Zhenwei Peng, M. Kuang, 2022, Hepatology.

Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study

Shuling Chen, Zhenwei Peng, Shuang Wu, 2023, Journal of Hematology & Oncology.